Keywords
vestibular schwannoma - vestibular neuroma - intratumoral bleeding - cerebellopontine
angle tumors
Palavras-chave
schwannoma vestibular - neuroma vestibular - sangramento intratumoral - tumores do ângulo pontocerebelar
Introduction
Vestibular schwannomas (VSs) account for 8% of intracranial tumors and ∼ 70% of all
tumors of the cerebellopontine angle (CPA).[1] The clinical presentation is often insidious, with progressive hearing loss and
involvement of other cranial nerves (CNs), primarily the facial (VII) and the trigeminal
(V) nerves. Spontaneous hemorrhage in those tumors is very unusual, and generally
presents with acute clinical features, resulting in higher mortality.[2]
Case Report
A 66-year-old female patient, a 30-year smoker with a history of heavy alcohol consumption,
was hospitalized for gastrointestinal bleeding, and underwent a computed tomography
(CT) scan for evaluation. The CT scan evidenced an expansive lesion in the cerebellopontine
region. A magnetic resonance imaging (MRI) scan of the brain revealed a lesion with
a 2.5-cm diameter, with the features that characterize a VS. The patient was referred
to neurosurgery for treatment after 1 month, and a new MRI showed a 1-cm increase
in the lesion, as well as intratumoral bleeding.
In the preoperative evaluation, the patient presented right auditory deficit, as well
as facial and trigeminal nerve deficits, with no history of neurological comorbidities.
Subtotal surgical resection of the tumor was performed, combined with neuromonitoring,
and there were no complications during this period. In the immediate postoperative
period, the patient progressed well, reaching a score of 15 on the Glasgow Coma Scale
(GCS). About 12 hours after the end of the procedure, the patient presented disorientation,
decreasing to GCS 12, without focal deficits. An emergency CT scan evidenced an epidural
hematoma in the surgical site. The patient was then taken again to surgery, with evacuation
of the hematoma, and decompressive craniectomy of the suboccipital region. The patient
presented a slight improvement in the sensorium, but after 6 hours she evolved to
coma. A new CT scan was performed, evidencing an important cerebellar bleeding. A
new surgical procedure was performed, but no clinical improvement was achieved. The
patient became irresponsive, GCS 3, with fixed and dilated pupils, and died ∼ 24 hours
later.
Discussion
Vestibular schwannomas are tumors originating from Schwann cells, which form the myelin
sheath, and arise from the superior and inferior vestibular portions of the eighth
CN.[1] The incidence rate of VS is of ∼ 1.2 per 100 thousand people per year, and this
rate is expected to rise, partly due to incidental diagnoses.[3] Vestibular schwannomas are rare, comprising ∼ 8–10% of primary intracranial tumors,
70–85% of CPA tumors, and 90% of intracranial schwannomas.[1]
[4]
The diagnosis is made, on average, on patients around 50 years of age; 90% of the
cases are unilateral, and the involvement is equal on both sides.[2] The symptoms are usually insidious, and are mainly caused by vestibular-cochlear
nerve involvement. Approximately 95% of the patients have hearing loss, although only
2/3 are aware of that loss, and tinnitus (60%) is usually among the clinical features.[3] Vestibular involvement occurs in 61% of the cases, and most patients acknowledge
unsteadiness while walking. The trigeminal nerve can also be affected in up to 17%
of the patients, as well as the facial nerve in 6% of the cases.[5] Though unusual, the presentation can be of catastrophic onset, resulting from sudden,
massive intratumoral hemorrhage or subarachnoid hemorrhage (SAH).[5] The management of elderly patients diagnosed with VS is generally conservative,
consisting of observation and routine radiographic monitoring of tumor size progression
and new symptom development.[3]
Vestibular schwannomas are isointense to hypointense to brain on T1-weighted images,
and hyperintense on T2-weighted images and enhanced after the administration of intravenous
(IV) contrast. They may be heterogeneous due to cystic degeneration, hemorrhage or
vascularity.[6] Vestibular schwannomas are histologically benign tumors, and a significant proportion
of them are either non-growing or slow-growing; therefore, observation is a commonly
accepted option in case of small oligosymptomatic tumors (< 2.5 cm in size). Microsurgery
is indicated mainly in the case of large tumors, the deterioration of useful hearing
during observation with attempt for its preservation, and in the case of disabling
symptoms.[4]
Hemorrhage from brain tumors accounts for 1–11% of intracranial bleeding, and 1–2%
of the hemorrhages occur beneath the arachnoid membrane including the 3 following
types: SAH, intratumoral hemorrhage (ITH) with SAH, and intracerebral hematoma surrounding
the brain tumor with SAH.[7] Severe bleeding causes complications in up to 10% of the cases.[2] Intratumoral hemorrhage within a VS, however, is considered a rare event.[8]
[9]
[10] It has been historically reported in less than 1% of the cases.[9] Advances in imaging and larger analyses suggest that ITH is far more common than
what was previously believed, and it might represent an aspect of the natural history
of VS.[9]
Different theories have been proposed to explain the pathogenesis of the hemorrhage.
An invasion of the vascular wall by tumor cells, and vascular proliferation followed
by necrosis are plausible explanations.[8] Hypertension, contusion of the tumor, and rapid growth are also blamed for the hemorrhage
in cases of acoustic neurinoma. Marked increase in arterial and venous pressure by
physical exercise and traumatic contusion of the tumor may rupture the fragile tumor
vessels, resulting in massive hemorrhage in cases of acoustic neurinoma. A rapidly
growing tumor disrupts the adjacent thin-walled and dilated vessels, leading to massive
hemorrhage into the surrounding tissue, where stromal support is weak.[5] Different risk factors have been suggested for ITH in cases of VS, which include
tumor size (> 2 cm), abnormal vasculature, radiosurgery, and rapid growth of the tumor.
The use of anticoagulants, methotrexate, cocaine, and trauma may result in ITH, even
though only a few cases have been reported.[7]
[8]
[9]
Most patients with neuroma-related hemorrhage presented with nausea, vomiting, headache
and altered consciousness, usually with marked dysfunction of the CN involved, and
commonly with new deficits of the neighboring CNs. Asymptomatic patients, as in our
case, were described in very few reports.[2]
[10] The clinical impact of ITH in cases of VS is likely substantial, as the existing
literature records an increased prevalence of CN-VII palsy at presentation and an
increased rate of death when compared with non-hemorrhagic cases. For example, the
reported incidence of CN-VII palsy in large series of cases of VS is of ∼ 6%, but
a review by Niknafs et al of hemorrhagic VSs revealed CN-VII palsy in 31.3% of the
cases.[9]
The prognosis of the patients with ITH secondary to a neoplasm is usually poor.[5] However, a variable prognosis is described in cases of hemorrhagic VS.[2] Surgical evacuation of the hematoma and tumor excision comprise the preferred method
of treatment for hemorrhage in cases of acoustic neurinoma. Batuk et al mention 1
series in which, out of 36 patients who underwent surgery, only 2 died, and all the
rest had uneventful postoperative courses and good outcomes.[5]
Conclusion
Intratumoral bleeding in cases of VS is rare, and usually presents with acute symptoms,
such as neurological deterioration or SAH.[11] In the present case, we report a patient with an accidental discovery of the tumor,
which evolved with rapid growth and bleeding, but without clinical changes. Even after
surgical resection, the prognosis varies greatly, from total recovery and return to
daily activities to death,[2] which was the progression of our patient's condition.